# OXCARBAZEPINE
> **ANDA211420** · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS · Approved 2021-07-09
## Drug
- **FDA Application Number:** ANDA211420
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** Oxcarbazepine
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PAI HOLDINGS
- **First approval:** 2021-07-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211420)
---
*AI Analytics · CC0 1.0*